OTLK Latest Headlines

Catalyst Watch: Micron earnings, Amazon Prime Day, and stress tests for major banks

at seekingalpha.com (Fri, 19-Jun 12:00 PM)

FDA Sets July Decision Date for Outlook Therapeutics’ ONS-5010—Anticipation Builds for First FDA-Approved Ophthalmic Bevacizumab

Market Chameleon (Tue, 16-Jun 11:06 AM)

Outlook Therapeutics’ Resubmitted ONS-5010 BLA Accepted by FDA

at www.tipranks.com (Tue, 16-Jun 9:49 AM)

Outlook gains as wet AMD therapy reconsidered for FDA review

at seekingalpha.com (Tue, 16-Jun 9:23 AM)

FDA Appeal Win Clears Path for Outlook Therapeutics' LYTENAVA—Resubmission Expected Next Month

Market Chameleon (Wed, 27-May 10:33 AM)

FDA Appeal Win Clears Path for Outlook Therapeutics' ONS-5010/LYTENAVA to Resubmit for Approval

Market Chameleon (Tue, 26-May 9:52 AM)